Real-world data and real-world evidence are important when it comes to cancer research because they can complement and expand findings from randomized clinical trials The post Real-world data 101: an overview appeared first on ECOG-ACRIN Advocacy Blog.| ECOG-ACRIN Advocacy Blog
This registry study is collecting real-world data on patients with advanced, EGFR-positive non-small cell lung cancer who may not have had the opportunity, wanted to, or been eligible to enroll in a trial The post Now Enrolling: This lung cancer patient registry study by PrECOG aims to better understand an FDA-approved treatment appeared first on ECOG-ACRIN Advocacy Blog.| ECOG-ACRIN Advocacy Blog